1.Construction and Practice of AI-Based Triadic Interactive Teaching Model for Surgical Animal Surgery
Kaikai MAO ; Xiu LI ; Chen ZHOU ; Jianfeng SANG ; Meng WANG ; Guang ZHANG ; Xiaozhi ZHAO
Laboratory Animal and Comparative Medicine 2026;46(2):288-296
ObjectiveIn the context of the digital transformation of education, this study aims to construct a triadic interactive teaching model for surgical animal surgery in clinical medicine using modern information technology. It explores the effectiveness of different teaching methods in improving students' practical skills, aseptic awareness, and teamwork abilities, providing a reference for the reform of clinical practice education. MethodsA quasi-experimental research design was adopted. A total of 80 students from the eight-year clinical medicine program at Nanjing University were selected, including the Class of 2020 (control group, n=40) and the Class of 2021 (experimental group, n=40). The control group received traditional teaching methods, while the experimental group implemented the "Teacher-Student-AI" triadic interactive teaching model. This model utilized a smart teaching platform for personalized pre-class preparation , as well as data-driven post-class review and feedback throughout the entire teaching process. The "assessment indicators and scoring criteria for the surgical animal surgery course" were used to evaluate teaching effectiveness, with independent samples t-tests used for statistical analysis. ResultsPre-course assessments revealed no statistically significant differences in baseline theoretical knowledge or practical skills between the two groups (P>0.05). Upon completion of the course, the experimental group achieved higher scores than the control group across three key dimensions: practical skills (47.98±1.34 vs 46.92±2.51, P=0.022), aseptic awareness (17.84±1.16 vs 16.94±2.29, P=0.029), and teamwork (16.82±1.44 vs 15.95±1.22, P=0.004). However, no statistically significant difference was observed in the scores for humane care awareness between the two groups (8.24±0.70 vs 8.16±0.53, P=0.589). ConclusionThe AI-based triadic interactive teaching model can, to some extent, address the limitations of traditional surgical animal surgery education. It plays a positive role in enhancing medical students' surgical skills, aseptic awareness, and collaborative abilities. This model facilitates the transition from traditional to personalized teaching and offers a practical framework for the digital reform of clinical practice education.
2.Spatiotemporal distribution of etiologically positive pulmonary tuberculosis in Shaanxi Province, 2015-2023
Kaikai LI ; Lihui DANG ; Hongwei ZHANG ; Zhiqiang HE
Chinese Journal of Epidemiology 2025;46(7):1180-1187
Objective:To understand the spatiotemporal distribution of pulmonary tuberculosis (TB) in Shaanxi Province from 2015 to 2023, and provide reference for the prevention and control of pulmonary TB in Shaanxi.Methods:The registration data of etiologically positive pulmonary TB cases in Shaanxi from 2015 to 2023 were collected from the tuberculosis subsystem of Chinese Disease Control and Prevention Information System. Descriptive method was used to analyze the basic characteristics of the etiologically positive pulmonary TB cases. Linear trend χ2 test was used to analyze trends in registration rate and pathogen positive rate. Software SPSS 25.0 was used for statistical analysis. Software ArcGIS 10.8 was used for global spatial autocorrelation and hotspot analysis to explore spatial clustering of the etiologically positive pulmonary TB cases. Software SaTScan 10.0 was used for spatiotemporal scan statistics, and software ArcGIS 10.8 was used to visualize the spatiotemporal clustering. Results:A total of 64 148 cases of etiologically positive pulmonary TB were registered in Shaanxi from 2015 to 2023, with an average annual registration rate of 18.33/100 000. The registration rate and pathgen positive rate all showed upward trends from 2015 to 2023, and the differences were significant (the trend χ2=4 555.18 and 19 330.43, both P<0.001). Global spatial autocorrelation and hotspot analysis showed that the registration rate of etiologically positive pulmonary TB in Shaanxi from 2017 to 2023 showed a spatial clustering. The hotspots were mainly in Zhenba and Xixiang counties of Hanzhong, six counties (districts) of Ankang, and Yanchuan and Yanchang counties of Yan'an. The coldspots were mainly in parts of the Guanzhong area, including Baoji, Xi'an, and Xianyang. A total of 4 spatiotemporal clustering areas were explored by spatiotemporal scanning analysis (all P<0.001), in which the first-level clustering areas covered 17 counties (districts), mainly Zhenping, Ziyang, Zhenba, in southern Shaanxi from 2019 to 2022, the second-level clustering areas covered 6 counties (districts), mainly Yanchuan, Yanchang, Qingjian, in northern Shaanxi from 2018 to 2021, the third-level clustering areas covered 14 counties (districts), mainly Yanta, Chang'an, Jingyang, in Guanzhong area from 2018 to 2019, and the fourth-level clustering areas covered 10 counties (districts) from 2019 to 2021. Conclusions:The registration rate of labortory confirmed pulmonary TB cases in Shaanxi showed an upward trend, with obvious differences in spatiotemporal clustering distribution. The clustering areas were mainly in southern Shaanxi, such as Zhenba, Zhenping, Hanbin, Langao, Pingli, Xunyang, Ziyang counties, and northern Shaanxi, such as Yanchuan and Yanchang counties, as well as in capital city, Xi'an and the adjacent Guanzhong area. It is necessary to develope targeted measures according to local conditions for the improvement of pulmonary TB prevention and control strategies in Shaanxi.
3.Robot-assisted surgery for renal cell carcinoma in a pilot: a case report and literature review
Xintao LI ; Jinxuan ZHANG ; Haibo SHENG ; Jun WANG ; Di LI ; Jizhang XING ; Jingmin YAN ; Dawei MU ; Kaikai CHEN ; Xiaolong WEI ; Shuwei XIAO ; Bin SUN ; Jianye LI
Chinese Journal of Aerospace Medicine 2025;36(2):145-149
Objective:To investigate the selection of treatment methods for renal tumors in pilots as well as the clinical significance of robot-assisted surgery by summarizing the process of robot-assisted surgery in the treatment of renal cell carcinoma in a pilot.Methods:The diagnosis, robot-assisted surgery and aeromedical assessment of a pilot with renal cell carcinoma were reported, and the related literature was reviewed.Results:The patient was a 44-year-old male transporter pilot, who was diagnosed with a left renal mass in the middle-lower pole of the kidney during a routine abdominal CT scan. After detailed preoperative evaluation that ruled out the possibility of distant metastasis and other surgical contraindications, the patient underwent robot-assisted laparoscopic partial nephrectomy in August 2022. The postoperative recovery went well, and renal function remained within normal limits at follow-ups. In March 2023, the pilot was concluded as qualified for flight after aeromedical assessment.Conclusions:Robot-assisted partial nephrectomy can significantly reduce surgical trauma, lower the risk of complications, and maximally preserve renal function. It is a good approach to renal tumors in pilots who can recover quickly.
4.Epidemiological characteristics analysis of pulmonary tuberculosis among children aged 0-14 in Shaanxi Province from 2010 to 2024
HE Zhiqiang, ZHAO Yan, LI Kaikai, ZHANG Hongwei
Chinese Journal of School Health 2025;46(9):1346-1350
Objective:
To analyze the epidemiological characteristics and incidence trends of pulmonary tuberculosis (TB) in children aged 0-14 years in Shaanxi Province from 2010 to 2024, so as to provide a reference for optimizing child TB prevention and control strategies.
Methods:
Data on pulmonary TB cases in children aged 0-14 years and demographic information in Shaanxi Province from 2010 to 2024 were collected from Surveillance and Reporting Management System with Disease Prevention and Control Information Management System under the National Health Security Informatization Project Disease Prevention and Control Information System. A Joinpoint regression model was established to analyze the temporal, spatial, and population distribution trends of child pulmonary TB incidence.
Results:
A total of 2 954 cases of pulmonary TB in children aged 0-14 years were reported in Shaanxi Province from 2010 to 2024, accounting for 0.97% of all TB cases in the general population. The average annual reported incidence rate in children was 3.32 per 100 000. Among these cases, 804 were pathogenetically positive, showing a increasing trend ( χ 2 trend =420.94, P < 0.01 ). The overall reported incidence rate of pulmonary TB in children aged 0-14 years in Shaanxi Province showed a decreasing trend, dropping from 5.35 per 100 000 in 2010 to 2.41 per 100 000 in 2024. Joinpoint regression analysis identified three distinct phases for the reported incidence rate of TB:a rapid decline from 2010 to 2013 (APC=-20.02%, 95% CI = -33.64% to -10.42%), a slight increase from 2013 to 2017 (APC=11.18%, 95% CI =3.07%-24.17%) and a slight decline again from 2017 to 2024 (APC= -7.27 %, 95% CI =-12.73% to -4.30%) (all P <0.01). Among children aged 0-14 years, the age group with the highest average annual reported incidence rate was 10-14 years (8.02 per 100 000), followed by 5-9 years (1.44 per 100 000), and 0-4 years had the lowest rate (0.95 per 100 000). The difference in reported incidence rates among the three age groups was statistically significant ( χ 2= 51.91, P <0.01). The average annual reported incidence rate of TB was 3.25 per 100 000 in boys and 3.39 per 100 000 in girls, with no statistically significant difference ( χ 2=2.01, P >0.05). There was no obvious periodic variation in the annual case reporting. Among all cities in Shaanxi Province, Ankang City had the highest average annual reported incidence rate (5.16 per 100 000).
Conclusions
From 2010 to 2024, the reported incidence rate of pulmonary TB in children aged 0-14 years in Shaanxi Province showed an overall decreasing trend. However, it is still necessary to strengthen active surveillance, implement targeted measures in high incidence areas such as Ankang City, and maintain continuous attention to child TB prevention and control.
5.Treatment outcome and influencing factors of rifampicin-resistant pulmonary tuberculosis patients in Shaanxi Province from 2017 to 2022
Kaikai LI ; Zhanfeng HAN ; Hongwei ZHANG ; Zhiqiang HE
Chinese Journal of Infectious Diseases 2025;43(10):599-605
Objective:To analyze the treatment outcome and its related factors of rifampicin-resistant pulmonary tuberculosis (RR-PTB) patients in Shaanxi Province from 2017 to 2022.Methods:Through the "Drug-resistant Cases" in the "Surveillance Report Management" subsystem of the "China Disease Control and Prevention System", the RR-PTB patients registered from January 1st, 2017 to December 31st, 2022 in Shaanxi Province were collected.A cross-sectional study was used to analyze the epidemiological characteristics, history of anti-tuberculosis treatment, medication status, and treatment outcomes and prognosis of the patients was performed. The trend analysis was conducted by trend chi-square test. Chi-square test was used for statistical comparison. Multivariable logistic regression model was used to analyze factors influencing the treatment outcome of RR-PTB patients.Results:From 2017 to 2022, a total of 2 582 cases of RR-PTB were registered in Shaanxi Province. Epidemiological characteristics showed that the male registration incidence (1.55/100 000) was higher than that of females (0.61/100 000), and the difference was statistically significant ( χ2=473.04, P<0.001). The population was mainly young and middle-aged (38.88%(1 004/2 582)) and farmers (66.50%(1 717/2 582)). The highest registered incidence was in Southern Shaanxi (1.71/100 000). A total of 1 567 cases were successfully treated, with a successful treatment rate of 60.69%. The successful treatment rate of RR-PTB patients increased from 58.17%(121/208) in 2017 to 66.41%(174/262) in 2022, which showed an overall upward trend with statistically significant (trend χ2=62.84, P<0.001). The multivariable logistic regression analysis showed that male (odds ratio ( OR)=1.838, 95% confidence interval ( CI) 1.392 to 2.427, P<0.001), 45 to 64 years old ( OR=2.119, 95% CI 1.361 to 3.300, P=0.001), ≥65 years old ( OR=5.070, 95% CI 3.016 to 8.521, P<0.001), living the Northern Shaanxi ( OR=1.639, 95% CI 1.087 to 2.471, P=0.018), retreatment ( OR=1.646, 95% CI 1.264 to 2.144, P<0.001), with cross-regional mobility ( OR=1.821, 95% CI 1.403 to 2.363, P<0.001), cumulative months of medication <6 months ( OR=55.310, 95% CI 40.267 to 75.974, P<0.001), family member or self-medication management ( OR=2.176, 95% CI 1.527 to 3.100, P<0.001) were risk factors for successful treatment of RR-PTB patients. Conclusions:The successful treatment rate of RR-PTB patients in Shaanxi Province has shown an upward trend.Male, age ≥45 years, living in the Northern Shaanxi, retreatment, cross-regional mobility, cumulative months of medication <6 months, family or self-medication management are risk factors for treatment outcome of RR-PTB patients.Treatment management, the supervision and propaganda education should be strengthened to further reduce the risk of adverse treatment outcomes.
6.Efficacy and safety of split-dose cisplatin neoadjuvant chemotherapy for muscl-einvasive bladder cancer
Kaikai CHEN ; Jing LI ; Hailong LIU ; Ding XU ; Shun ZHANG ; Shenggen YU ; Yu SHEN ; Zhiwei CHEN ; Haibo SHEN
Journal of Modern Urology 2025;30(10):842-847
Objective To compare the efficacy and safety of gemcitabine combined with conventional-dose cisplatin(70 mg/m2,day 2)versus split-dose cisplatin(35 mg/m2,days 1 and 8)in neo-adjuvant therapy for muscle-invasive bladder cancer(MIBC).Methods The clinical data of 33 MIBC patients receiving(gemcitabine+cisplatin,GC)-based neoadjuvant chemotherapy in the Department of Urology of Xinhua Hospital,during Jan.2021 and Aug.2024 were retrospectively analyzed,including 18(54.5%)patients treated with a conventional-dose regimen(GC group),and 15(45.5%)patients treated with a split-dose regimen(GCs group).The efficacy endpoints and incidence/severity of adverse reactions were compared between the two groups.Results Baseline characteristics were well-balanced between the two groups(P>0.05).No significant differences were observed in the complete response rate(CR:33.3%vs.22.2%),objective response rate(ORR:66.7%vs.61.1%),or disease control rate(DCR:80.0%vs.88.9%)between the GCs and GC groups(P>0.05).The GCs group exhibited a significantly lower incidence of chemotherapy-related renal injury(6.7%vs.38.9%,P<0.05),while the occurrence of other adverse events was comparable between the two groups.Notably,the GCs group demonstrated significantly attenuated nephrotoxicity,as evidenced by markedly smaller changes in estimated glomerular filtration rate[eGFR:(4.5±4.7)%vs.(18.0±11.8)%]and serum creatinine[SCr:(5.7±5.6)%vs.(20.2±19.5)%]compared to the GC group(P<0.05).Conclusion Compared with the conventional-dose regimen,the split-dose regimen maintains equivalent clinical efficacy of GC-based neoadjuvant chemotherapy while significantly reducing chemotherapy-related nephrotoxicity,thereby providing MIBC patients with a safer therapeutic option.
7.Efficacy and safety of split-dose cisplatin neoadjuvant chemotherapy for muscl-einvasive bladder cancer
Kaikai CHEN ; Jing LI ; Hailong LIU ; Ding XU ; Shun ZHANG ; Shenggen YU ; Yu SHEN ; Zhiwei CHEN ; Haibo SHEN
Journal of Modern Urology 2025;30(10):842-847
Objective To compare the efficacy and safety of gemcitabine combined with conventional-dose cisplatin(70 mg/m2,day 2)versus split-dose cisplatin(35 mg/m2,days 1 and 8)in neo-adjuvant therapy for muscle-invasive bladder cancer(MIBC).Methods The clinical data of 33 MIBC patients receiving(gemcitabine+cisplatin,GC)-based neoadjuvant chemotherapy in the Department of Urology of Xinhua Hospital,during Jan.2021 and Aug.2024 were retrospectively analyzed,including 18(54.5%)patients treated with a conventional-dose regimen(GC group),and 15(45.5%)patients treated with a split-dose regimen(GCs group).The efficacy endpoints and incidence/severity of adverse reactions were compared between the two groups.Results Baseline characteristics were well-balanced between the two groups(P>0.05).No significant differences were observed in the complete response rate(CR:33.3%vs.22.2%),objective response rate(ORR:66.7%vs.61.1%),or disease control rate(DCR:80.0%vs.88.9%)between the GCs and GC groups(P>0.05).The GCs group exhibited a significantly lower incidence of chemotherapy-related renal injury(6.7%vs.38.9%,P<0.05),while the occurrence of other adverse events was comparable between the two groups.Notably,the GCs group demonstrated significantly attenuated nephrotoxicity,as evidenced by markedly smaller changes in estimated glomerular filtration rate[eGFR:(4.5±4.7)%vs.(18.0±11.8)%]and serum creatinine[SCr:(5.7±5.6)%vs.(20.2±19.5)%]compared to the GC group(P<0.05).Conclusion Compared with the conventional-dose regimen,the split-dose regimen maintains equivalent clinical efficacy of GC-based neoadjuvant chemotherapy while significantly reducing chemotherapy-related nephrotoxicity,thereby providing MIBC patients with a safer therapeutic option.
8.Treatment outcome and influencing factors of rifampicin-resistant pulmonary tuberculosis patients in Shaanxi Province from 2017 to 2022
Kaikai LI ; Zhanfeng HAN ; Hongwei ZHANG ; Zhiqiang HE
Chinese Journal of Infectious Diseases 2025;43(10):599-605
Objective:To analyze the treatment outcome and its related factors of rifampicin-resistant pulmonary tuberculosis (RR-PTB) patients in Shaanxi Province from 2017 to 2022.Methods:Through the "Drug-resistant Cases" in the "Surveillance Report Management" subsystem of the "China Disease Control and Prevention System", the RR-PTB patients registered from January 1st, 2017 to December 31st, 2022 in Shaanxi Province were collected.A cross-sectional study was used to analyze the epidemiological characteristics, history of anti-tuberculosis treatment, medication status, and treatment outcomes and prognosis of the patients was performed. The trend analysis was conducted by trend chi-square test. Chi-square test was used for statistical comparison. Multivariable logistic regression model was used to analyze factors influencing the treatment outcome of RR-PTB patients.Results:From 2017 to 2022, a total of 2 582 cases of RR-PTB were registered in Shaanxi Province. Epidemiological characteristics showed that the male registration incidence (1.55/100 000) was higher than that of females (0.61/100 000), and the difference was statistically significant ( χ2=473.04, P<0.001). The population was mainly young and middle-aged (38.88%(1 004/2 582)) and farmers (66.50%(1 717/2 582)). The highest registered incidence was in Southern Shaanxi (1.71/100 000). A total of 1 567 cases were successfully treated, with a successful treatment rate of 60.69%. The successful treatment rate of RR-PTB patients increased from 58.17%(121/208) in 2017 to 66.41%(174/262) in 2022, which showed an overall upward trend with statistically significant (trend χ2=62.84, P<0.001). The multivariable logistic regression analysis showed that male (odds ratio ( OR)=1.838, 95% confidence interval ( CI) 1.392 to 2.427, P<0.001), 45 to 64 years old ( OR=2.119, 95% CI 1.361 to 3.300, P=0.001), ≥65 years old ( OR=5.070, 95% CI 3.016 to 8.521, P<0.001), living the Northern Shaanxi ( OR=1.639, 95% CI 1.087 to 2.471, P=0.018), retreatment ( OR=1.646, 95% CI 1.264 to 2.144, P<0.001), with cross-regional mobility ( OR=1.821, 95% CI 1.403 to 2.363, P<0.001), cumulative months of medication <6 months ( OR=55.310, 95% CI 40.267 to 75.974, P<0.001), family member or self-medication management ( OR=2.176, 95% CI 1.527 to 3.100, P<0.001) were risk factors for successful treatment of RR-PTB patients. Conclusions:The successful treatment rate of RR-PTB patients in Shaanxi Province has shown an upward trend.Male, age ≥45 years, living in the Northern Shaanxi, retreatment, cross-regional mobility, cumulative months of medication <6 months, family or self-medication management are risk factors for treatment outcome of RR-PTB patients.Treatment management, the supervision and propaganda education should be strengthened to further reduce the risk of adverse treatment outcomes.
9.Robot-assisted surgery for renal cell carcinoma in a pilot: a case report and literature review
Xintao LI ; Jinxuan ZHANG ; Haibo SHENG ; Jun WANG ; Di LI ; Jizhang XING ; Jingmin YAN ; Dawei MU ; Kaikai CHEN ; Xiaolong WEI ; Shuwei XIAO ; Bin SUN ; Jianye LI
Chinese Journal of Aerospace Medicine 2025;36(2):145-149
Objective:To investigate the selection of treatment methods for renal tumors in pilots as well as the clinical significance of robot-assisted surgery by summarizing the process of robot-assisted surgery in the treatment of renal cell carcinoma in a pilot.Methods:The diagnosis, robot-assisted surgery and aeromedical assessment of a pilot with renal cell carcinoma were reported, and the related literature was reviewed.Results:The patient was a 44-year-old male transporter pilot, who was diagnosed with a left renal mass in the middle-lower pole of the kidney during a routine abdominal CT scan. After detailed preoperative evaluation that ruled out the possibility of distant metastasis and other surgical contraindications, the patient underwent robot-assisted laparoscopic partial nephrectomy in August 2022. The postoperative recovery went well, and renal function remained within normal limits at follow-ups. In March 2023, the pilot was concluded as qualified for flight after aeromedical assessment.Conclusions:Robot-assisted partial nephrectomy can significantly reduce surgical trauma, lower the risk of complications, and maximally preserve renal function. It is a good approach to renal tumors in pilots who can recover quickly.
10.Spatiotemporal distribution of etiologically positive pulmonary tuberculosis in Shaanxi Province, 2015-2023
Kaikai LI ; Lihui DANG ; Hongwei ZHANG ; Zhiqiang HE
Chinese Journal of Epidemiology 2025;46(7):1180-1187
Objective:To understand the spatiotemporal distribution of pulmonary tuberculosis (TB) in Shaanxi Province from 2015 to 2023, and provide reference for the prevention and control of pulmonary TB in Shaanxi.Methods:The registration data of etiologically positive pulmonary TB cases in Shaanxi from 2015 to 2023 were collected from the tuberculosis subsystem of Chinese Disease Control and Prevention Information System. Descriptive method was used to analyze the basic characteristics of the etiologically positive pulmonary TB cases. Linear trend χ2 test was used to analyze trends in registration rate and pathogen positive rate. Software SPSS 25.0 was used for statistical analysis. Software ArcGIS 10.8 was used for global spatial autocorrelation and hotspot analysis to explore spatial clustering of the etiologically positive pulmonary TB cases. Software SaTScan 10.0 was used for spatiotemporal scan statistics, and software ArcGIS 10.8 was used to visualize the spatiotemporal clustering. Results:A total of 64 148 cases of etiologically positive pulmonary TB were registered in Shaanxi from 2015 to 2023, with an average annual registration rate of 18.33/100 000. The registration rate and pathgen positive rate all showed upward trends from 2015 to 2023, and the differences were significant (the trend χ2=4 555.18 and 19 330.43, both P<0.001). Global spatial autocorrelation and hotspot analysis showed that the registration rate of etiologically positive pulmonary TB in Shaanxi from 2017 to 2023 showed a spatial clustering. The hotspots were mainly in Zhenba and Xixiang counties of Hanzhong, six counties (districts) of Ankang, and Yanchuan and Yanchang counties of Yan'an. The coldspots were mainly in parts of the Guanzhong area, including Baoji, Xi'an, and Xianyang. A total of 4 spatiotemporal clustering areas were explored by spatiotemporal scanning analysis (all P<0.001), in which the first-level clustering areas covered 17 counties (districts), mainly Zhenping, Ziyang, Zhenba, in southern Shaanxi from 2019 to 2022, the second-level clustering areas covered 6 counties (districts), mainly Yanchuan, Yanchang, Qingjian, in northern Shaanxi from 2018 to 2021, the third-level clustering areas covered 14 counties (districts), mainly Yanta, Chang'an, Jingyang, in Guanzhong area from 2018 to 2019, and the fourth-level clustering areas covered 10 counties (districts) from 2019 to 2021. Conclusions:The registration rate of labortory confirmed pulmonary TB cases in Shaanxi showed an upward trend, with obvious differences in spatiotemporal clustering distribution. The clustering areas were mainly in southern Shaanxi, such as Zhenba, Zhenping, Hanbin, Langao, Pingli, Xunyang, Ziyang counties, and northern Shaanxi, such as Yanchuan and Yanchang counties, as well as in capital city, Xi'an and the adjacent Guanzhong area. It is necessary to develope targeted measures according to local conditions for the improvement of pulmonary TB prevention and control strategies in Shaanxi.


Result Analysis
Print
Save
E-mail